Hepatitis C virus infection is associated with the development of hepatocellular carcinoma - PubMed (original) (raw)
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma
I Saito et al. Proc Natl Acad Sci U S A. 1990 Sep.
Abstract
A possible causative role for the recently discovered hepatitis C virus (HCV) in the development of hepatocellular carcinoma (HCC) was investigated by assay of sera from HCC patients in Japan for antibodies to a recombinant HCV antigen and to hepatitis B virus (HBV) antigens. Among the 253 HCC patients examined, 156 (61.7%) had no serum markers of either a previous or a current HBV infection (group I), 46 (18.2%) were negative for HBV surface antigen but positive for anti-HBV surface and/or anti-HBV core antibody, indicating the occurrence of a previous, transient HBV infection (group II), and 51 (20.2%) were chronically infected HBV carriers as evidenced by positivity for HBV surface antigen (group III). The prevalence of HCV antibody in group I (68.6%) and II (58.7%) patients was significantly higher than for group III (3.9%) or in 148 additional patients with other (non-HCC) cancers (10.1%) (P less than 0.01). Thus, there appears to be a strong association between HCV infection and the development of HCC, particularly in patients for which HBV infection cannot be implicated as a causative factor. The data also suggest an additional mode of transmission for HCV other than blood transfusion, since a history of blood transfusion was shown in only about 30% of the HCV antibody-positive HCC patients in groups I and II. A high prevalence of HCV antibody was also shown among patients with HCC whose disease was originally thought to be due to very high ethanol consumption.
Similar articles
- Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y, Tani M, Kurata T, Abe K. Edamoto Y, et al. Cancer. 1996 May 1;77(9):1787-91. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1787::AID-CNCR5>3.0.CO;2-9. Cancer. 1996. PMID: 8646675 - Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
Suga M, Senota A, Arima K, Kodama T, Ikuta S, Sakamoto H, Ohe Y, Sugai S, Yachi A. Suga M, et al. Hepatogastroenterology. 1994 Oct;41(5):438-41. Hepatogastroenterology. 1994. PMID: 7531667 - Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic.
Tsega E, Nordenfelt E, Hansson BG. Tsega E, et al. Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):171-4. doi: 10.1016/0035-9203(95)90482-4. Trans R Soc Trop Med Hyg. 1995. PMID: 7539952 - Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS. Chen DS. Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review. - [Co-infection of HBV with HCV and a possible role of HBV DNA in hepatocarcinogenesis].
Koike K. Koike K. Nihon Rinsho. 1999 Jan;57(1):213-9. Nihon Rinsho. 1999. PMID: 10036965 Review. Japanese.
Cited by
- Chronic Hepatitis C: Acute Exacerbation and Alanine Aminotransferase Flare.
Kanda T, Matsumoto N, Ishii T, Arima S, Shibuya S, Honda M, Sasaki-Tanaka R, Masuzaki R, Kanezawa S, Nishizawa T, Gon Y, Ogawa M, Kogure H. Kanda T, et al. Viruses. 2023 Jan 8;15(1):183. doi: 10.3390/v15010183. Viruses. 2023. PMID: 36680223 Free PMC article. Review. - Understanding the Immunoenvironment of Primary Liver Cancer: A Histopathology Perspective.
Chung A, Nasralla D, Quaglia A. Chung A, et al. J Hepatocell Carcinoma. 2022 Nov 2;9:1149-1169. doi: 10.2147/JHC.S382310. eCollection 2022. J Hepatocell Carcinoma. 2022. PMID: 36349146 Free PMC article. Review. - Hepatitis C Virus Nonstructural Protein 5A Interacts with Immunomodulatory Kinase IKKε to Negatively Regulate Innate Antiviral Immunity.
Kang SM, Park JY, Han HJ, Song BM, Tark D, Choi BS, Hwang SB. Kang SM, et al. Mol Cells. 2022 Oct 31;45(10):702-717. doi: 10.14348/molcells.2022.0018. Epub 2022 Aug 22. Mol Cells. 2022. PMID: 35993162 Free PMC article. - Hepatitis C virus infection reduces the lifespan of chimpanzees used in biomedical research.
Hirata S, Havercamp K, Yamanashi Y, Udono T. Hirata S, et al. Biol Lett. 2022 Aug;18(8):20220048. doi: 10.1098/rsbl.2022.0048. Epub 2022 Aug 10. Biol Lett. 2022. PMID: 35946233 Free PMC article. - Toll-like Receptor Response to Hepatitis C Virus Infection: A Recent Overview.
Kayesh MEH, Kohara M, Tsukiyama-Kohara K. Kayesh MEH, et al. Int J Mol Sci. 2022 May 13;23(10):5475. doi: 10.3390/ijms23105475. Int J Mol Sci. 2022. PMID: 35628287 Free PMC article. Review.
References
- Dig Dis Sci. 1983 Oct;28(10):908-11 - PubMed
- Gastroenterology. 1983 Sep;85(3):743-68 - PubMed
- Am J Gastroenterol. 1984 Oct;79(10):777-81 - PubMed
- Arch Pathol Lab Med. 1987 Feb;111(2):170-3 - PubMed
- Cancer Res. 1988 Dec 15;48(24 Pt 1):7294-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical